STOCK TITAN

NuRAN Wireless Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Rhea-AI Summary

NuRAN Wireless (NASDAQ:NUR) received a Nasdaq deficiency notification after its common shares traded below the US$1.00 minimum bid price requirement. Received November 10, 2026, the letter is not a delisting notice and has no immediate effect on listing or trading. Business operations are unaffected.

NuRAN has until May 10, 2027 to regain compliance by maintaining a closing bid price of at least US$1.00 for at least ten consecutive business days; Nasdaq may require longer. An additional 180-calendar-day period is conditional on eligibility and written notice of intent to cure the deficiency, potentially through a reverse stock split. Failure to cure or qualify for more time could lead to delisting, subject to appeal. Management intends to monitor the bid price and consider available compliance options.

Loading...
Loading translation...
0 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

0 major · 7 points

Hollow bars mark forward-looking points. How the balance works

Positive

  • None.

Negative

  • Moderate pointMinimum bid price deficiency followed 30 consecutive business days below US$1.00, September 29–November 9, 2026.
  • Moderate point. Forward-looking: it has not happened yet and may not happen.Delisting risk remains if Nasdaq determines NuRAN cannot cure the deficiency or is ineligible for additional time.
  • Minor point. Forward-looking: it has not happened yet and may not happen.May 10, 2027 compliance deadline requires closing bids of at least US$1.00 for at least ten consecutive business days.
  • Minor point. Forward-looking: it has not happened yet and may not happen.Nasdaq discretion may extend the required compliance streak beyond ten business days, generally not exceeding 20.
  • Minor point. Forward-looking: it has not happened yet and may not happen.Additional 180-calendar-day period depends on US$1 million publicly held share market value and other initial listing standards, excluding bid price.
2 minor points
  • Minor point. Forward-looking: it has not happened yet and may not happen.Extension eligibility also requires written intent to cure, through a reverse stock split if necessary.
  • Minor point. Forward-looking: it has not happened yet and may not happen.Any elected reverse split must be completed no later than ten business days before May 10, 2027.
Argus 15 min delay 3 alerts
+3.27% vs previous close $0.4169 last price 0.6x rel. volume Open Argus
Details

Market move: NUR +3.27% vs previous close. Nasdaq bid-price deficiency

$0.37 – $0.43 Day Range
$5.50M Mkt Cap at Last Price

On Nov 13, the day this news came out, the latest delayed price for NUR is 3.27% above the previous close. Our momentum scanner has recorded 3 alerts for this stock so far that day. The latest delayed price is $0.42.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.

Key Figures

Previous close: $0.394 per share Minimum bid price: US$1.00 per share Deficiency period: 30 consecutive business days +4 more
Previous close
$0.394 per share
Nov 12, 2026, before the notice was published
Minimum bid price
US$1.00 per share
Nasdaq Capital Market requirement
Deficiency period
30 consecutive business days
Period below the minimum bid price before notification
Initial compliance period
180 calendar days
To regain compliance, through May 10, 2027
Required compliance duration
At least 10 consecutive business days
Closing bid price must meet or exceed US$1.00
Additional compliance period
180 calendar days
May be available if Nasdaq’s stated eligibility conditions are met
Publicly held shares market value
US$1 million
One stated condition for eligibility for an additional compliance period

Key Terms

reverse stock split
1 terms
reverse stock split financial
"by effecting a reverse stock split, if necessary."
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

QUEBEC, QC / ACCESS Newswire / November 13, 2026 / NuRAN Wireless Inc. (NASDAQ:NUR)(FSE:1RN) ("NuRAN" or the "Company"), a provider of rural connectivity infrastructure in Africa, today announces that on November 10, 2026, it received a written notification letter (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") notifying NuRAN that it was not in compliance with Nasdaq Listing Rule 5550(a)(2), as the minimum bid price of the Company's common shares ("Shares") has been below US$1.00 per share for 30 consecutive business days.

The Notification Letter is only a notification of deficiency and not a notice of delisting. As such, the Notification Letter has no immediate effect on the listing or trading of the Company's Shares on the Nasdaq Capital Market under the symbol "NUR."

Nasdaq Listing Rules

Nasdaq Listing Rule 5550(a)(2) requires securities listed on the Nasdaq Capital Market to maintain a minimum bid price of US$1.00 per share, and Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days. Based on the closing bid price of the Company's Shares for the 30 consecutive business days from September 29, 2026, to November 9, 2026, the Company has not met the minimum bid price requirement.

In accordance with Nasdaq Listing Rule 5810(c)(3)(A), NuRAN has a period of 180 calendar days, or until May 10, 2027, to regain compliance with the minimum bid price requirement. To regain compliance, the closing bid price of the Company's Shares must meet or exceed US$1.00 for at least ten consecutive business days during this 180-calendar day compliance period. Nasdaq may, in its discretion, require the Company to satisfy the minimum bid price requirement for a period of more than ten consecutive business days, generally not exceeding 20 consecutive business days, before determining that the Company has demonstrated an ability to maintain long-term compliance.

If the Company does not regain compliance by May 10, 2027, it may be eligible for an additional 180-calendar-day compliance period, provided that it meets the continued listing requirement for market value of publicly held shares (US$1 million) and all other initial listing standards for the Nasdaq Capital Market, other than the minimum bid price requirement. The Company must also provide written notice to Nasdaq of its intention to cure the deficiency during the additional compliance period, by effecting a reverse stock split, if necessary. If the Company elects to implement a reverse stock split, Nasdaq requires that it be completed no later than ten business days prior to the expiration of the initial 180-calendar-day compliance period ending May 10, 2027.

If it appears to Nasdaq that NuRAN will not be able to cure the deficiency, or if NuRAN is not otherwise eligible for additional time to regain compliance, the Company's Shares will be subject to delisting by Nasdaq. NuRAN may appeal any Nasdaq determination to delist its Shares, and during any appeal process, the Company's Shares would continue to trade on the Nasdaq Capital Market.

NuRAN's management intends to actively monitor the bid price for its Shares and will consider all available options to regain compliance with the Nasdaq minimum bid price requirement.

The Company's business operations are not affected by the receipt of the Notification Letter.

About NuRAN Wireless

NuRAN Wireless Inc. (Nasdaq:NUR)(FSE:1RN) is a rural telecommunications infrastructure company connecting remote and underserved communities across Africa. Through its Network-as-a-Service model, NuRAN finances, builds, owns, operates and maintains 2G, 3G and 4G mobile network infrastructure for mobile network operators seeking to expand coverage outside urban markets.

NuRAN has more than 5,000 towers under contract, a portion of which have been built and are operating. Its platform combines telecommunications engineering, low-power wireless technology, renewable-energy-enabled infrastructure, site selection and field operations to address the economic and technical challenges of rural mobile coverage.

NuRAN is also building on this foundation through NuEnergy, its wholly owned subsidiary focused on owning and operating the Company's solar, storage and hybrid power systems across its African footprint.

Additional Information:

For further information about NuRAN Wireless: www.nuranwireless.com
Francis Létourneau, Director and CEO
Francis.letourneau@nuranwireless.com
Tel: (418) 264-1337

Forward-Looking Statements

This news release contains forward-looking statements and forward-looking information (collectively, "forward-looking statements") within the meaning of applicable Canadian securities laws, including the securities laws of the Province of British Columbia, and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements other than statements of historical fact are forward-looking statements. Forward-looking statements are generally, but not always, identified by words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "potential," "project," "seek," "should," "target," "will," "would" and similar expressions, or by statements that certain events, actions or results "may," "could," "should," "would" or "will" occur, be achieved or be realized.

Forward-looking statements in this news release include, without limitation, statements regarding the Company's intention to monitor its minimum bid price, its consideration of available alternatives to regain compliance with Nasdaq's minimum bid price requirement, the Company's ability to regain compliance within the applicable compliance period, the potential implementation of a reverse stock split, the Company's potential eligibility for an additional compliance period and the continued listing of the Company's securities on the Nasdaq Capital Market.

Forward-looking statements are not guarantees of future performance, and actual results may differ materially from those expressed or implied by such statements. Forward-looking statements are based on management's current expectations, estimates, assumptions and projections and are subject to known and unknown risks, uncertainties and other factors that may cause actual results to differ materially, including risks relating to the Company's ability to regain compliance with Nasdaq's minimum bid price requirement; fluctuations in the market price and trading volume of the Company's Shares; the Company's ability to satisfy Nasdaq's continued listing requirements; Nasdaq's discretion in determining whether the Company has regained compliance or is eligible for an additional compliance period; the potential implementation and effectiveness of any reverse stock split; and the risk that Nasdaq may determine to delist the Company's securities.

Additional risks and uncertainties are described under "Risk Factors" and elsewhere in the Company's most recent annual report on Form 40-F, subsequent reports furnished on Form 6-K and other filings with the U.S. Securities and Exchange Commission, and in the Company's filings on SEDAR+ at www.sedarplus.ca.

Readers are cautioned not to place undue reliance on forward-looking statements. There can be no assurance that the Company will regain compliance with Nasdaq's minimum bid price requirement, qualify for an additional compliance period or maintain its listing on the Nasdaq Capital Market. The forward-looking statements in this news release speak only as of its date and are expressly qualified in their entirety by this cautionary note. Except as required by applicable securities laws, the Company undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

SOURCE: NuRAN Wireless Inc.



View the original press release on ACCESS Newswire

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Why did NuRAN Wireless receive a Nasdaq minimum bid price notice?

NuRAN received the notice because its shares remained below US$1.00 for 30 consecutive business days, from September 29 to November 9, 2026. The notification, received November 10, 2026, concerns Nasdaq Listing Rule 5550(a)(2).

What is NuRAN Wireless's deadline to regain Nasdaq bid price compliance?

NuRAN has until May 10, 2027 to regain compliance. Its closing bid price must meet or exceed US$1.00 for at least ten consecutive business days during the compliance period. Nasdaq may require a longer streak, generally not exceeding 20 consecutive business days.

Can NuRAN Wireless appeal a Nasdaq delisting determination?

NuRAN may appeal any Nasdaq determination to delist its shares. Its shares would continue trading on the Nasdaq Capital Market during the appeal process.

Keep reading